Technical Analysis for CMTA - Clementia Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade A 26.35 -0.11% -0.03
CMTA closed down 0.11 percent on Wednesday, April 17, 2019, on 1.57 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Extremely Strong Up Up Flat
See historical CMTA trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 76.37%
NR7 Range Contraction 76.37%
Upper Bollinger Band Walk Strength 76.37%
Inside Day Range Contraction 76.37%
Overbought Stochastic Strength 76.37%
Shooting Star Candlestick Bearish 77.08%
Lizard Bearish Bearish Day Trade Setup 77.08%
Upper Bollinger Band Walk Strength 77.08%
Overbought Stochastic Strength 77.08%
Upper Bollinger Band Touch Strength 77.08%

Older signals for CMTA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and activates retinoic acid receptor gamma (an RARg agonist), and has activity in preventing abnormal new bone formation as well as scar tissue formation (or fibrosis) in a variety of tissues in animal models. It is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). Its programs focus on diseases involving tissue transformation via retinoic acid receptors (RARs). The Company also has an eye drop formulation of palovarotene that can potently increase tear production and decrease corneal damage.
Diseases Chemical Compounds Rare Diseases Cell Biology Scar Fibrosis Intracellular Receptors Pyrazoles Transcription Factors
Is CMTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 26.73
52 Week Low 8.1
Average Volume 277,568
200-Day Moving Average 14.6356
50-Day Moving Average 23.1856
20-Day Moving Average 26.134
10-Day Moving Average 26.272
Average True Range 0.3658
ADX 76.95
+DI 38.648
-DI 4.5041
Chandelier Exit (Long, 3 ATRs ) 25.6326
Chandelier Exit (Short, 3 ATRs ) 26.8474
Upper Bollinger Band 26.5309
Lower Bollinger Band 25.7371
Percent B (%b) 0.77
BandWidth 3.037423
MACD Line 0.7462
MACD Signal Line 0.9709
MACD Histogram -0.2247
Fundamentals Value
Market Cap 804.39 Million
Num Shares 30.5 Million
EPS -472.48
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.97
Resistance 3 (R3) 27.01 26.85 26.86
Resistance 2 (R2) 26.85 26.69 26.83 26.83
Resistance 1 (R1) 26.60 26.60 26.52 26.56 26.79
Pivot Point 26.44 26.44 26.40 26.42 26.44
Support 1 (S1) 26.19 26.28 26.11 26.15 25.91
Support 2 (S2) 26.03 26.19 26.01 25.87
Support 3 (S3) 25.78 26.03 25.84
Support 4 (S4) 25.74